Lifecore Biomedical, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses), averaging -35.1% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q1 FY27 | $-0.17 | $-0.19 | -11.8% | Miss | |
| Q4 FY26 | $-0.24 | $-0.43 | -79.2% | Miss | |
| Q3 FY26 | $-0.14 | $-0.16 | -14.3% | Miss |
Back to LFCR overview · LFCR holders · LFCR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.